Effects Of Muscle Energy Technique Versus Mobilization

September 17, 2021 updated by: Riphah International University

Effects Of Muscle Energy Technique Versus Mobilization On Pain And Disability In Post-Partum Females With Sacroiliac Joint Dysfunction.

The aim is to describe the severity of pain in postpartum female and management of sacroiliac joint pain and disability and define the effects of manual therapy on sacroiliac joint dysfunction and pain

Study Overview

Detailed Description

The aim is to describe the severity of pain in postpartum female and management of sacroiliac joint pain and disability and define the effects of manual therapy on sacroiliac joint dysfunction and pain in postpartum females and to check whether the amount of gaining range of movement is similar among postpartum female undergoing with mobilization therapy and with muscle energy technique.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Rawalpindi, Punjab, Pakistan, 46000
        • Pakistan Railway Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 20-40 year having unilateral back pain around or on sacral sulcus,
  • Positive posterior pain provocation test for Sacroiliac joint dysfunction,
  • Low back pain within six weeks of delivery
  • Pain while sitting down, lying on the ipsilateral side of pain, or climbing stairs.
  • Local tenderness of the posterior aspect of the sacroiliac joint
  • Pain is usually localized over the buttock.
  • Sharp, stabbing, and/or shooting pain which extends down the posterior thigh usually not past the knee.
  • C-section

Exclusion Criteria:

  • Neurological deficit
  • Spinal tumors
  • Scoliosis,
  • Underwent spinal surgery and prolapsed
  • Intervertebral disc with or without radiculopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group A
mobilization technique
Mobilization of sacroiliac joint which will increase the range of motion and reduction in pain and improvement in functional limitation.
Experimental: Group B
muscle energy technique
Muscle energy technique it is known as active muscular relaxation technique. It helps in lengthening the shorten muscle and increasing range of restricted muscles

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric pain rating scale
Time Frame: 4th week
o The 11-point (numeric pain rating scale) NPRS will use to capture the patient's level of pain. The scale is anchored on the left with the phrase ''no pain'' and on the right with the phrase ''worst imaginable pain.'' Patients rate their current level of pain and their worst and least amount of pain in the last 24 hours. The average of the 3 ratings or any single rating may be used to represent the patient's level of pain. Numeric pain scales have been shown to be reliable and valid. The reliability of numeric pain rating scale is 0.74
4th week
Modified Oswestry disability index
Time Frame: 4th week
It is a self-report questionnaire of a patient's perceived disability based on 10 areas of pain and daily activities (pain intensity, personal hygiene, lifting, walking, sitting, standing, sleeping, sexual activity, social activity and travelling). Each section is scored on a6-point scale (0-5), with 0 representing no limitation and 5 representing maximal limitation. The subscales combined add up to a total maximal score of 50. The score is then doubled and interpreted as a percentage of the patient-perceived disability (the higher the score, the greater the disability). In cases where patients did not answer all the 10 sections, the sum score of the answered sections were divided by the number of completed sections. The reliability of modified oswestry disability index is 0.88.
4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2020

Primary Completion (Actual)

August 20, 2021

Study Completion (Actual)

August 20, 2021

Study Registration Dates

First Submitted

March 7, 2021

First Submitted That Met QC Criteria

March 7, 2021

First Posted (Actual)

March 10, 2021

Study Record Updates

Last Update Posted (Actual)

September 23, 2021

Last Update Submitted That Met QC Criteria

September 17, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REC/00846 Nusrat Javed

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe